Roivant and Priovant Therapeutics hold an investor webinar on Brepocitinib and the Unmet Medical Need in Dermatomyositis on June 17 at 1 pm. roiv/register.aspx?conf=cc&page=roiv&url=https://wsw.com/webcast/cc/roiv/1393344′ target= ‘_blank’; rel=’nofollow’>Webcast Link
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROIV:
- Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
- Pulmovant announces publication of PK, lung deposition data for mosliciguat
- Strategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
- Roivant Sciences Reports Progress and Financial Results
- Roivant Sciences Earnings Call: Balancing Growth and Challenges